Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for NIACIN
- A Study of Niacin Regulation
- Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery
- Effect of Nicotinic Acid in Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial
- Pilot Trial of Supplemental Vitamin A and Nicotinamide
- Protective Effect of Zingiber Officinale L. Extract in Hypertensive Patients
- 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
- Effect of Adjunctive Use of Vitamin B3 and B9 on Myeloperoxidase Level in the GCF of Patients With Stage I and II Periodontitis
- Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
- A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder
- A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment
- Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI
- Study of Niacin in Glioblastoma
- The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
- Pathways of Eicosanoid Metabolism
- Visual Surround Suppression and Perceptual Expectation Under Psilocybin
- A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma
- Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
- Effects of Niacin on Intramyocellular Fatty Acid Trafficking in Upper Body Obesity and Type 2 Diabetes Mellitus
- A Study of Psilocybin for Major Depressive Disorder (MDD)
- The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
- Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
- The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients
- Extended Release Niacin and Fenofibrate for the Treatment of Atherogenic Dyslipidemia in Obese Females
- Regulation of Endogenous Glucose Production by Central KATP Channels
- Study of Gemcabene in Adults With FPLD
- Effects of Psyllium on Niacin Tolerability
- Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
- Early Life Interventions for Childhood Growth and Development In Tanzania
- The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis
- Nicotinamide as an Early Alzheimer's Disease Treatment
- Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
- Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
- Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)
- Randomized Trial Comparing Colesevelam vs. Ezetimibe
- FS2 Safety and Tolerability Study in Healthy Volunteers
- Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment
- Early Aortic Valve Lipoprotein(a) Lowering Trial
- Niacin on Immune Activation : a Proof-of-concept Study
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Epanova® for Lowering Very High Triglycerides II (EVOLVE II)
- Assessment Of Vascular Health After Niacin Therapy (AVANT)
- Effects of Niacin On Fatty Acid Trapping
- Short-term Effect of Extended-release Niacin on Endothelial Function.
- Benefit of Elevation of HDL-C in Women
- Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
- Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis
- Effects of Micronutrient (Chromium) Supplementation on Diabetes
- ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
- Gulf War Illness: Evaluation of an Innovative Detoxification Program
- A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158)
- Exploratory Study of Plaque Regression
- Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
- Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)
- Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease
- A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels
- Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)
- Effect of Niacin in the Lipoprotein (a) Concentration
- Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease
- A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)
- Biosynthesis of PGD2 in Vivo
- Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)
- Effect of Pharmacological Anti-lipolysis on FFA and VLDL-TG Metabolism Before and During Exercise
- Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
- Effect of Niacin/Laropiprant on Postprandial Lipoprotein Metabolism in Patients With Dyslipoproteinemia
- Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy
- Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
- Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)
- Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis
- Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia
- The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin
- Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America
- Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
- Niacin/Laropiprant and Endothelial Function
- Comparison of Fenofibrate and Niacin in Patients With Hypertriglyceridemia and Low High-Density Lipoprotein (HDL)-Cholesterol
- Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome
- Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow
- The Effect of Niacin Administration on Oxidative Stress in Patients With Hypercholesterolmia, as Measured by the Use of a Novel Biomarker
- Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers
- The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients
- Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users
- Study of Trilipix Effects on Lipids and Arteries
- Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
- Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels
- Pilot Trial of Statin Use in Burn Patients
- A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102)
- Psilocybin Cancer Anxiety Study
- The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
- MK0524A Bioequivalence Study (0524A-059)
- MK0524B Bioequivalence Study (0524B-070)
- Role of Prostaglandins on Niacin-Induced Flushing
- Study to Test GSK256073 in Patients With Dyslipidemia
- Alternative Options to Minimize Niacin-Induced Flushing
- Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
- Niacin and Endothelial Function in Early CKD
- Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
- Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
- A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
- Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
- Supplements for Controlling Resistance to Insulin
- Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse
- Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082)
- Safety/Efficacy Study of Oxycodone HCl/Niacin to Treat Pain After Bunionectomy
- Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)
- Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)
- Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin
- Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
- A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)
- A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers
- Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women
- MK0524A Phase IIb Study (0524A-011)(COMPLETED)
- Endpoint Validation Study (0524A-015)
- Effect of MK0524A on Flushing Caused by Niacin (0524A-056)
- MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED)
- Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
- Niacin to Improve Blood Flow in People With Sickle Cell Disease
- Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
- To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions
- Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)
- An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
- Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
- An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
- Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
- High-Density Lipoprotein (HDL) Treatment Study
- Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
- A Trial of Zinc and Micronutrients in Tanzanian Children
- Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants
- Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
- Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
- Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis
- Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)
- Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)
- Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
- Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
- The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)
- Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
- Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
- Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
- Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
- Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
- Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL
- Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)
- Niacin, N-3 Fatty Acids and Insulin Resistance
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
- Obesity and Nonalcoholic Fatty Liver Disease
- Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
- Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia
- The Low HDL On Six Weeks Statin Therapy (LOW) Study
- A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
- Lactate Metabolism Study in HIV Infected Persons
- SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
- TB Nutrition, Immunology and Epidemiology
- High-Density Lipoprotein (HDL) Modulation and Endothelial Function
- Treatment of Acute Schizophrenia With Vitamin Therapy
- High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
- Niacin Plus Statin to Prevent Vascular Events
- MARS - Monitored Atherosclerosis Regression Study
- An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)
- Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST
- Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)
- Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
- The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC
- Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication
- Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
- Cholesterol-Lowering Atherosclerosis Study (CLAS)
- HDL-Atherosclerosis Treatment Study (HATS)
- Arterial Disease Multifactorial Intervention Trial (ADMIT)
- Familial Atherosclerosis Treatment Study
- Coronary Drug Project Mortality Surveillance
- Coronary Drug Project
- Harvard Atherosclerosis Reversibility Project (HARP)
Clinical trials list
click for details